Brind.

FDA approved Pasatru for FOP treatment.

2 reports, 1 independent Updated Aug 29

Gone quiet

Reports: 2
Developments: 1
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

FDA approved Pasatru for FOP treatment.

Who's involved

What this event is mainly about

FDA Regeneron Pharmaceuticals

Keep exploring

The entities involved

FDA
- Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
- A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
Regeneron Pharmaceuticals
American pharmaceutical company
- Regeneron Pharmaceuticals and Wave Life Sciences are being compared as healthcare companies.Sun 14:10

Related events

A study protocol involving a company based in Mont-Saint-Guibert was approved by the U.S. FDA.Sep 2

Coverage

Newest first; wire copies grouped

Aug 29yahoo.com
Aug 29yahoo.com